Comparison

Melanotan-1 vs Melanotan II

The single most important point is that Melanotan-1 and Melanotan II are not the same compound and should not be treated as interchangeable. Melanotan-1 is afamelanotide, an MC1R-selective alpha-MSH analog with an FDA-approved product (SCENESSE) for a rare light-sensitivity disorder. Melanotan II is a different, more potent, non-selective melanocortin agonist that is not approved by any regulator and has documented risks. This page exists to keep the two apart, and it does not present Melanotan II tanning use as safe.

Reviewed for accuracy · Last reviewed July 8, 2026

Side by side

Melanotan-1Melanotan II
MoleculeAfamelanotide (alpha-MSH analog)Melanotan II (a different, more potent peptide)
Receptor selectivityMC1R-selectiveNon-selective across MC1R, MC3R, MC4R, MC5R
Approved productSCENESSE implant, FDA- and EMA-approvedNone; not approved by any regulator
Approved indicationErythropoietic protoporphyria (EPP), a rare disorderNo approved indication
Approved form and route16 mg controlled-release subcutaneous implant, clinician-placedGray-market subcutaneous injection; no validated dose
Documented safety concernsImplant-site reactions, nausea, headache; moles can darken (monitor skin)Priapism, mole changes, and melanoma case reports

Which is right for you

This is a disambiguation, not a head-to-head. Melanotan-1 is afamelanotide, and as the branded implant SCENESSE it is FDA-approved (2019) to increase pain-free light exposure in adults with erythropoietic protoporphyria. That approval is narrow and specific: it is a clinician-placed implant for a rare disorder, not a tanning product.

Melanotan II is a separate molecule. It is non-selective across several melanocortin receptors, which is why it affects pigmentation, appetite, sexual function, and cardiovascular tone at once, and it is not approved by any regulator for any use. Published case reports describe priapism, eruptive atypical moles, and melanoma associated with its use. Case reports cannot prove causation, but these are documented concerns rather than theoretical ones, and agencies have warned against the compound.

So neither is simply a better version of the other. Melanotan-1 has one approved use in a defined patient group; the injectable tanning use sold under either name is unapproved, and for Melanotan II specifically it carries risks that any new or changing mole should prompt a dermatology review over. None of this is medical advice, and the gray-market products sold for tanning may be mislabeled or contaminated.

FAQ

Are Melanotan-1 and Melanotan II the same thing?No. Melanotan-1 (afamelanotide) is an MC1R-selective molecule with an approved product (SCENESSE) for erythropoietic protoporphyria. Melanotan II is a different, more potent, non-selective peptide that is not approved for any use. They should not be treated as interchangeable.
Is either one safe for tanning?Injectable tanning use is not approved for either. Melanotan-1's only approval is the SCENESSE implant for a rare disorder, not tanning. Melanotan II is unapproved and linked in case reports to priapism, mole changes, and melanoma. Any new or changing mole warrants a dermatology review.

References

  1. Afamelanotide for Erythropoietic ProtoporphyriaNew England Journal of Medicine · 2015 · PMID 26132941 · DOI 10.1056/NEJMoa1411481
  2. SCENESSE (afamelanotide) implant: DailyMed labelDailyMed (U.S. National Library of Medicine) · current · DailyMed setid 94f53286-11dd-7fbb-e053-2a95a90a7c48
  3. Melanotan-induced priapism: a hard-earned tanBMJ Case Reports · 2019 · PMID 30796078 · DOI 10.1136/bcr-2018-227644
  4. Eruptive dysplastic nevi following melanotan useActas Dermo-Sifiliográficas · 2012 · PMID 22425244 · DOI 10.1016/j.ad.2011.10.001
  5. Melanoma Associated with the Use of Melanotan-IIDermatology (Karger) · 2014 · DOI 10.1159/000356389
  6. Melanotan IIDermNet (New Zealand) · 2015 · DermNet clinical reference topic

This page is an independent educational reference and is not medical advice. The approval described applies only to the SCENESSE implant for erythropoietic protoporphyria, not to tanning use. Talk to a doctor before starting any compound.